Cooperative Agreement U58DP004996

The George Washington University received a $226,504 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to study tobacco use trajectories and related mechanisms among U.S. adults and youth representing minority and intersecting minority identities. The objective is to test the central hypothesis that individuals with intersecting minority identities will demonstrate distinct tobacco use behaviors and related mechanisms, such as marketing...

This Project Grant award, with a total funding amount of $957,600.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will be used by Drexel University to develop a novel framework for community-directed research approaches that seek to reduce intersectional and intergenerational inequities in commercial tobacco use among Black and Latinx adult sexual and gender minorities in Philadelphia. Key activities...

This $399,187 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support research at Virginia Commonwealth University to study the role of ATG16L1 isoforms in colorectal cancer health disparities. The key objectives are to: 1) Determine whether the ATG16L1 T300T isoform, which is more predominant in African Americans, promotes more aggressive colorectal tumor growth and metastasis compared to the A300A isoform found more in...

This Project Grant award, provided by the National Cancer Institute (CFDA 93.396 Cancer Biology Research), will fund research at the University of California, San Francisco (UCSF) aimed at investigating the biological mechanisms behind racial disparities in head and neck cancer outcomes, particularly among Black patients. The $714,062 grant, awarded on April 15, 2025, with a completion date of March 31, 2030, will support two key research objectives: 1) Developing a tailored RNA prognostic model...

The Northwest Network of Bisexual/Trans Lesbians and Gay Survivors of Abuse will use a $441,537 Project Grant from the Department of Justice Office on Violence Against Women to provide advocacy services for LGBT survivors of domestic violence, sexual assault, and stalking. The grant funding will support the organization's work under the Grants for Outreach and Services to Underserved Populations program (CFDA #16.889) between October 1, 2021 and September 30, 2024. This particular grant aims...

This federal Project Grant award of $161,000.00 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports a pilot study by the University of Connecticut (UConn) to explore communication about sexuality and intimacy among individuals with metastatic breast cancer (MBC) and their partners. The key objectives of the study are to: 1) identify themes in MBC patients' communication about sexuality and intimacy, 2) determine if specific...

The LGBTQ Center of Durham, Inc. received a $600,000 Project Grant from the U.S. Department of Justice's Office on Violence Against Women under the Grants for Outreach and Services to Underserved Populations (CFDA# 16.889) program. The 3-year grant will fund efforts to enhance victim services for LGBTQIA+ survivors of sexual violence in the Central Piedmont region of North Carolina. Key activities include: embedding LGBTQIA+-specific advocates in rural service providers; conducting outreach...

Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pennsylvania a Project Grant of $220,576 under the Cancer Research Manpower program (CFDA 93.398) beginning August 1, 2025, and extending through July 31, 2030. The award funds a comprehensive tobacco treatment implementation (TTI) training and dissemination initiative designed to build clinical capacity for tobacco cessation interventions across healthcare organizations serving high-risk populations. The...

This $214,583 Project Grant awarded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to Tulane University will fund research to evaluate the role of the extracellular matrix in triple-negative breast cancer (TNBC) progression and treatment response, with a focus on African American patient populations. The research aims to provide insights on key extracellular matrix proteins that regulate TNBC tumorigenesis, metastasis, and response to therapy, using 3D in...

This federal Project Grant award, totaling $477,869.00, was provided by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395). The grant aims to develop tailored, multilevel cervical cancer interventions for ethnically diverse Black women, including African American women and Black African immigrant women. The key objectives are to: 1) identify multilevel determinants of routine cervical cancer screening and follow-up adherence among these populations,...